Introduction to Antibodies and Their Analytical Characterization

Introduction to Antibodies and Their Analytical Characterization

ON DEMAND

An expert from AstraZeneca will discuss the use of antibody drugs, how they function and the different techniques used to characterize them in the drug development process.

This is the fourth of five events in the Bruker COVID-19 Webinar Series.

During this webinar, Dr. Maurizio Muroni from Astra Zeneca, will deliver an introduction on what antibodies are, their structure and an overview of some of the analytical techniques used for their structural characterization.

Presenter:

Dr. Maurizio Muroni
Scientist
AstraZeneca

Dr. Maurizio Muroni was born in Sardinia where he gained a Laurea in Chimica, from University of Sassari, with a thesis on “Cyclic peptides (D, L alternate): synthesis, conformational analysis and molecular modelling”. Following, he moved to Cardiff where he graduated from a PhD in Biochemistry, Cardiff University – School of Chemistry, with a thesis on “ Rational design of artificial enzymes. After his PhD, Maurizio moved to London for an Industry based post doc between PolyTherics (now Abzena) and the School of Pharmacy, developing mass spectrometric methods for the characterization of PEGylated proteins. After two years he joined PolyTherics as Team Leader of Analytical Chemistry. And from 2014, he has been working at MedImmune/AstraZeneca as scientist working on the characterization of therapeutics protein in the Physiochemical Development team.

Other Webinars in this Series…

Treatments of COVID-19: Old Drugs, New Tricks

Treatments of COVID-19: Old Drugs, New Tricks

ON DEMAND

Dr. Niamh O'Boyle, from Trinity College in Dublin, provides an overview of the SARS-CoV-2 virus and discusses the drugs that are currently in use to treat COVID-19.

20200414102101